Bristol-Myers Squibb Co
DUS:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
DUS:BRM
|
US |
|
U
|
UniCredit SpA
OTC:UNCRY
|
IT |
|
V
|
Viasat Inc
DUS:VS1
|
US |
|
C
|
Canadian Natural Resources Ltd
F:CRC
|
CA |
|
Life Healthcare Group Holdings Ltd
F:L53
|
ZA |
|
A
|
Ameriprise Financial Inc
BMV:AMP
|
US |
|
Datatec Ltd
F:DTT
|
ZA |
|
G
|
Goodman Group
F:MY4
|
AU |
|
P
|
PICC Property and Casualty Co Ltd
F:PJC
|
CN |
|
Snam SpA
F:SNM0
|
IT |
|
M
|
MKS Instruments Inc
XMUN:MKT
|
US |
|
S
|
Swire Pacific Ltd
HKEX:87
|
HK |
|
H
|
Harley-Davidson Inc
XMUN:HAR
|
US |
|
G
|
GT Biopharma Inc
PAR:GTBP
|
US |
|
Anglo American Platinum Ltd
OTC:ANGPY
|
ZA |
|
P
|
Puma SE
F:PUM
|
DE |
|
Shoprite Holdings Ltd
F:HY7
|
ZA |
|
K
|
Keyence Corp
F:KEE
|
JP |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for
BRM is 53.63 EUR with a low forecast of 28.37 EUR and a high forecast of 66.82 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
53.63
EUR
According to Wall Street analysts, the average 1-year price target for
BRM is 53.63 EUR with a low forecast of 28.37 EUR and a high forecast of 66.82 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 6%.